LoginRegister
    No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDANo carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA
    Single-member NCLT bench to give finality to split verdict over Unimark Remedies resolutionSingle-member NCLT bench to give finality to split verdict over Unimark Remedies resolution
    DCGI nod to Lincoln pharma Diclofenac Rectal Spray for reducing types of painDCGI nod to Lincoln pharma Diclofenac Rectal Spray for reducing types of pain
    J&J CEO testified Baby Powder was safe 13 days before FDA bombshellJ&J CEO testified Baby Powder was safe 13 days before FDA bombshell
    Syngene reports robust 11% YOY revenue growth in Q2 FY20Syngene reports robust 11% YOY revenue growth in Q2 FY20
    Lupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in USLupin gets USFDA nod for generic equivalent of Depakote ER Tablets to treat epilepsy in US
    AstraZeneca Farxiga approved in US to reduce heart failure risk in Type-2 diabetesAstraZeneca Farxiga approved in US to reduce heart failure risk in Type-2 diabetes
    CDSCO directs drug regulators to strictly monitor end-use of dual-use APIsCDSCO directs drug regulators to strictly monitor end-use of dual-use APIs
    GSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billionGSK to sell anti-rabies vaccines Rabipur, Encepur to Bavarian Nordic for USD 1.1 billion
    Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCCRoche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC
    Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from CentreHyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre
    Teva Pharma, 3 others reach tentative deal to settle opioid lawsuitTeva Pharma, 3 others reach tentative deal to settle opioid lawsuit
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X